Beruflich Dokumente
Kultur Dokumente
in 2019 and is
expected to reach US$ XX Bn. by 2027, at a CAGR of 6.8% during a forecast
period.
By Device, Electrocardiography ECG holds at least 40% of the share, and this
will be credited to the improved capacities of the new generation
Electrocardiograms. On the diagnostic and tracking front, a brand new
technology of portable and compact ECG is impelling its greater adoption, in
particular inside the home healthcare phase. There has been an upsurge in the
occurrence of cardiovascular diseases (CVD), wherein a long-term ECG
monitoring is vital and with the introduction of wireless ECG, doctors can
monitor and diagnose the patient remotely on time, which further boost the
market growth. Besides, growing cardiovascular illnesses, consisting of
arrhythmias, stroke, and excessive blood pressure, are growing the demand for
cardiovascular devices; in consort with mounting cognizance and demand for
minimally invasive surgeries are also anticipated to thrust the cardiovascular
device market.
In 2019, coronary heart disease held the most important market share of 41.9%
of the cardiovascular devices market, by application. The coronary heart
disease segment is expected to rule its market share in 2027 because of the
growing incidence of the disease.
The North America cardiovascular device market was valued at US$ XX million in
2019 and is expected to reach a value of US$ XX million by 2027, with a CAGR
of XX% during the forecast period. The increase of the cardiovascular devices
market is mainly accredited to the growing developments for cardiovascular
devices and the up surging aged populace. On the contradictory hand, mounting
medical tourism in Mexico is probably to have a fantastic impact on the growth
of the North American cardiovascular devices market in the upcoming years. The
cardiovascular devices market is majorly promoted by the changes or the
sifting in the trend of the technology that permits the players to develop
modern devices. The market is associated with numerous market leaders that are
carrying out numerous developmental activities for cardiovascular devices.
According to the American College of Cardiology, cardiovascular disorder (CVD)
accounted for 800,000 deaths in the United States in 2017 alone.
The Asia Pacific is anticipated to see the fastest growth during the forecast
period with Japan expected leading the general Asia Pacific market, followed
by China. China is predicted to have the largest geriatric population globally
with the highest obesity problem rates as a result of inactive life and bad
dietary habits. These factors are expected to raise the superiority of cardiac
diseases in this country, therefore definitely impacting the growth of the
Asia Pacific market. The mounting nations are substantially growing their
healthcare centers and offerings and are directing towards technological
improvements. For example, the structural heart is on the initial stage of the
activities improvement in regions such as the Asia Pacific and the Middle East
and Africa.
Key Development
• Electrocardiography (ECG)
• Stent
• Defibrillator
• Cardiac Catheter
• Guide wire
• Event Monitor
• Heart Valve
• Pacemaker
• Others
• Cardiac Centers
• Hospitals
• Ambulatory Surgical Centers
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)
• Siemens AG
• BD
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation
• Medtronic
• Biosense Webster, Inc (Johnson and Johnson)
• General Electric Company
• Koninklijke Philips N.V
• Boston Scientific Corporation
• Abbott
• Jarvik Heart
• Maquet Cardiovascular
• Merit Medical Systems
• On-X Life Technologies
• Orbusneich
• St. Jude Medical
• Sorin Group
• Spectranetics
• Sunshine Heart
• Syncardia Systems
• Thoratec
• Volcano